Lactobacillus salivarius
Lactobacillus salivarius, now named Ligilactobacillus salivarius, is a lactic acid bacterium that naturally lives in the human mouth and gut.
What happened in the bowel-symptom trial?
A trial assigned 77 people with irritable bowel syndrome to L. salivarius UCC4331, B. infantis 35624 or placebo for eight weeks. The consistent improvements in pain, bloating and bowel-movement difficulty concerned B. infantis. They should not be credited to L. salivarius. 1
A promising result for PS2
In a trial that randomized 328 pregnant women, supplementation ran from week 35 of pregnancy through 12 weeks after birth. Mastitis occurred in 6% of the PS2 group versus 14% with placebo. This was prevention in that setting, not treatment of an existing infection; the industry funder participated in the study and publication. 2
Effects by health goal
Open an effect to see the studies behind its rating. Bars show the size of the effect; the letter grades the evidence.
Gut Health4 effects
No study is linked to this rating.
No study is linked to this rating.
No study is linked to this rating.
No study is linked to this rating.
Immune Support2 effects
No study is linked to this rating.
No study is linked to this rating.
Other effects2 effects
No study is linked to this rating.